Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Prof Heidi Hudson appointed to international Committee on the Status of Women
2015-11-24

Prof Heidi Hudson is looking forward to advancing women scholars globally
Photo: Supplied

Prof Heidi Hudson, director of the Centre for Africa Studies at the University of the Free State, was recently appointed by the President of the International Studies Association (ISA) to serve on the Committee on the Status of Women from March 2016 to April 2018. 

Representing over 100 countries, ISA has more than 6 500 members in North America and internationally, and is the most respected and widely-known scholarly association in the field of International Studies. 

She anticipates that her role on the committee will complement her research interests in feminist security theory and practice in Africa. “I am looking forward to playing a part in the advancement of southern scholars, and the promotion of their voice in global academe.”   

Prior to Professor Hudson’s appointment, she served as a member of the executive of the Feminist Theory and Gender Studies (FTGS) Section of ISA.

Representing women of the world in academia

The Committee on the Status of Women has the task of reviewing the status of women in the profession, and making recommendations to the president and the Governing Council of ISA on ways of tracking and increasing the status and visibility of women in the profession.

“Some of the goals of the committee for the 2014 to 2016 period include reaching out to women scholars in the global south; creating an ISA networking website for women scholars; and surveying perceptions of the international relations climate and its needs,” said Prof Hudson. It is also responsible for “tracking gender balance within ISA and its journals, and supporting ISA regions in fulfilling the mission of the Committee on the Status of Women,” she added.

Connecting scholars globally since 1959

The ISA has been the premier organisation for connecting scholars and practitioners in fields of international studies, and promoting research and education. ISA cooperates with 57 international studies organisations in more than 30 countries, is a member of the International Social Science Council, and enjoys non-governmental consultative status at the United Nations.

Prof Hudson’s research interests concentrate on discursive and material gender deficits of liberal peacebuilding in the post colony, amongst other subjects. She is also co-editor of International Feminist Journal of Politics.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept